← Eichor
Study identifier: NCT04775706 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

Condition: Short Bowel Syndrome  ·  Sponsor: Hanmi Pharmaceutical Company Limited

PhasePhase 2
Planned participants18
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a randomized, double-blind, placebo-controlled, proof-of-concept (PoC), Phase 2 study to assess the safety, PK, and PD of SC administration of HM15912(sonefpeglutide) in adult subjects with SBS-associated intestinal failure (SBS-IF).

This description comes directly from the study's public registry record.

Talk to the study team

Wooyoung Amy Hong  ·  +82 2 410 9238  ·  wooyoung.hong@hanmi.co.kr

Always discuss trial participation with your own doctor first.

Locations (14)

Brigham & Women's HospitalBoston, Massachusetts, United StatesRecruiting
The Cleveland Clinic FoundationCleveland, Ohio, United StatesRecruiting
UZ LeuvenLeuven, Vlaams Brabant, BelgiumRecruiting
Rigshospitalet Department of Digestive Diseases, Transplantation and General Surgery Section for Intestinal FailureCopenhagen, DenmarkRecruiting
Hopital BeaujonClichy, Clichy, FranceRecruiting
Centre Hospitalier Universitaire de BordeauxBordeaux, FranceRecruiting
Les Hospices Civils de LyonLyon, FranceRecruiting
Centre Hospitalier Universitaire de NiceNice, FranceRecruiting
Asklepios Klinik St. GeorgHamburg, Free and Hanseatic City of Hamburg, GermanyRecruiting
Universitätsklinikum TübingenTübingen, Tübingen, GermanyRecruiting
Wojewodzki Specjalistyczny Szpital im. Mikołaja Pirogowa w ŁodziLodz, Łódź Voivodeship, PolandRecruiting
Samsung Medical CenterSeoul, South KoreaRecruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04775706